Skip to main content
. Author manuscript; available in PMC: 2018 Jul 10.
Published in final edited form as: Clin Lung Cancer. 2017 Feb 9;18(5):559–564. doi: 10.1016/j.cllc.2017.01.012

Figure 1. Absolute Lymphocyte Count (ALC) Trajectory Over 90 Days.

Figure 1

The log-transformed ALC for the first 90 days was plotted for patients with durable clinical benefit (DCB) and without DCB. A linear mixed effect model was used to evaluate the differences in slopes with P = .073.